Correction: <i>Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study</i>

20201 citationserratumgold Open Access

Authors

Charles Ferté · Amplimmune (United States)

Benjamin Frey · Friedrich-Alexander-Universität Erlangen-Nürnberg

Markus Hecht · Friedrich-Alexander-Universität Erlangen-Nürnberg

Rainer Fietkau · Bayer (Germany)

Nora Sundahl · Ghent University Hospital

Florian Putz · Friedrich-Alexander-Universität Erlangen-Nürnberg

Andrea Lancia

Abstract

Najjar YG, Navrazhina K, Ding F, et al . Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study. J Immunother Cancer 2020;8:e000331. doi: 10.1136/jitc-2019-000331 This article has been corrected since it was published online. The author, Igor

Topics & Keywords

Ocular Oncology and Treatments Nanoplatforms for cancer theranostics Immunotherapy and Immune Responses

UN Sustainable Development Goals

Zero hunger

Publication Details

Published in: Journal for ImmunoTherapy of Cancer

Volume 8, Issue 2, pp. e000331corr1-e000331corr1

DOI: 10.1136/jitc-2019-000331corr1

Field-Weighted Citation Impact: 0.19